Semaglutide for Type 2 Diabetes (2 mg): CADTH Health Technology Review [Internet]
Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct. Report No.: RC1507.
CADTH Health Technology Review.
Authors
Authors
;
Deepa Jahagirdar
,
Quenby Mahood
PMID:
38096343
Bookshelf ID:
NBK598216
No abstract available
Publication types
Review